Rhenman & Partners Asset Management’s BIND THERAPEUTICS INC BIND Stock Holding History

Rhenman & Partners Asset Management’s Portfolio BIND Stock Details BIND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-133,535	Closed	-$294K	–	102
2016 Q1	$294K	Hold	133,535	–	–	0.06%	91
2015 Q4	$306K	Hold	133,535	–	–	0.05%	95
2015 Q3	$596K	Hold	133,535	–	–	0.1%	91
2015 Q2	$746K	Hold	133,535	–	–	0.09%	96
2015 Q1	$733K	Hold	133,535	–	–	0.12%	88
2014 Q4	$721K	Buy	133,535 +25,000	+23%	+$187K	0.21%	82
2014 Q3	$932K	Hold	108,535	–	–	0.27%	91
2014 Q2	$1.43M	Buy	108,535 +48,535	+81%	+$475K	0.42%	76
2014 Q1	$718K	Buy	+60,000	New	+$784K	0.22%	85

Other funds holding BIND

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FMA

FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Rhenman & Partners Asset Management's BIND Position: Q2 2016 in Review

Rhenman & Partners Asset Management sold out of BIND THERAPEUTICS INC (BIND) in Q2 2016, closing a stake of 133,535 shares — an estimated $294K sold.

Rhenman & Partners Asset Management first reported a position in BIND in Q1 2014 and held it in 9 quarters. The position peaked at $1.43M in Q2 2014. 21 funds tracked by Wall St. Rank hold BIND as of Q2 2016.

Rhenman & Partners Asset Management reported no remaining BIND THERAPEUTICS INC position as of Q2 2016 after selling out during the quarter.
Rhenman & Partners Asset Management sold 133,535 BIND THERAPEUTICS INC shares in Q2 2016, an estimated $294K.
Rhenman & Partners Asset Management first reported a position in BIND THERAPEUTICS INC in Q1 2014 and held it in 9 quarters.
Rhenman & Partners Asset Management's BIND THERAPEUTICS INC position peaked at $1.43M in Q2 2014.
21 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q2 2016.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2016, filed 1 Aug 2016.